The Feedback Loop the Body Never Stops Running: On Hormones and the Tissue They Govern

There is a quality of invisibility to the endocrine system that makes it genuinely difficult to think about clearly. Unlike a muscle, you cannot feel a hormone working. Unlike blood pressure, you cannot watch it on a monitor. Hormones operate in concentrations so small — picograms per milliliter, in many cases — that the idea of them exerting meaningful force over the body's most consequential functions requires a small act of imagination. And yet that is precisely what they do.

What we sometimes miss, even when we understand the basics, is that hormones are not merely chemical messengers that trigger an event and then disappear. They are ongoing sculptors. The tissues they act on — muscle, bone, brain, fat, cardiovascular endothelium — are continuously being shaped by hormonal signals. When those signals are robust and well-coordinated, the sculpting happens in the direction of resilience. When they falter, the same tissues begin to drift, slowly and almost imperceptibly, in the other direction.

The Tissue Is Listening

Every major tissue in the body carries receptors tuned to specific hormonal frequencies. Testosterone receptors sit in skeletal muscle, bone, the brain, and the cardiovascular system. Estrogen receptors are distributed across neural tissue, arterial walls, bone, and skin. Thyroid hormone receptors are so ubiquitous that nearly every cell in the body has them — which is why thyroid dysfunction produces such a bewilderingly broad range of symptoms.

What this receptor distribution tells us is that hormones are not specialists. They are systems-level regulators. A shift in one — even a gradual, age-related shift that lands well within the conventional "normal" reference range — ripples through multiple tissue systems simultaneously. The fatigue someone attributes to poor sleep may in part reflect declining thyroid output slowing cellular energy production. The difficulty maintaining muscle mass despite consistent training may be inseparable from a testosterone decline that reduces muscle protein synthesis at the molecular level. The cognitive fog that feels like stress may have an endocrine dimension that stress alone cannot explain.

The question is never simply whether a hormone is present. It is whether it is present in quantities sufficient to maintain the tissues that depend on it.

This distinction — between presence and sufficiency — is where much conventional medicine loses the thread. Laboratory reference ranges are statistical constructs, built from population averages that include a great many people who are not functioning at their best. A result that clears the threshold for "normal" tells you very little about whether that individual's tissues are receiving the signal strength they need.

Testosterone, Women, and a Conversation That's Been Too Long Delayed

One of the more striking developments in endocrine research over the last several years has been a sustained, rigorous examination of testosterone's role in women — a conversation that was, for decades, largely absent from mainstream clinical practice. Research increasingly suggests that testosterone is not a male hormone that women happen to have in small amounts, but a hormone of genuine physiological consequence in female biology across the lifespan.

A 2022 review by Donovitz examined the accumulating evidence on testosterone therapy in women and found associations with improvements in energy, sexual function, mood, cognitive performance, and body composition — outcomes that correspond directly to the receptor systems discussed above, now understood to be active in women's tissues just as they are in men's (Donovitz, 2022). More recently, a position statement from the Latin American Association of Gynecological Endocrinology addressed androgen therapy in midlife and older women specifically, reflecting a growing clinical consensus that this dimension of female hormone health warrants serious, evidence-grounded attention (Pilnik et al., 2025).

This matters not because it opens a door to a new therapy, but because it corrects a long-standing blind spot. Women experiencing the energy, mood, and cognitive changes of perimenopause and beyond have often had only part of their endocrine picture examined. The androgen dimension — quiet, underappreciated, and measurable — has frequently gone unaddressed.

What Optimization Actually Means in Practice

The word "optimization" can sound aspirational in a way that distances it from biology. But in an endocrine context, it is a precise and practical concept. It means measuring what is actually circulating, comparing it against what the individual's tissue systems appear to need, and adjusting — carefully, incrementally, with ongoing monitoring — toward the range where the body seems to function best.

This is not the same as maximizing. Hormones operate within windows, not along unlimited upward curves. Estrogen without appropriate progesterone balance carries its own risks. Testosterone without monitoring of downstream conversion products — estradiol, dihydrotestosterone — can produce unintended consequences. The goal is not to push numbers higher but to restore a coherence to the system, to give the feedback loops that govern energy, body composition, mood, and cognition the input they need to run cleanly.

What makes that effort worthwhile — and what research is steadily reinforcing — is that the tissues respond. Muscle that had been resistant to rebuilding begins to respond to training again. Bone that was drifting toward lower density stabilizes. Cognitive function that had grown sluggish sharpens. These are not miraculous outcomes. They are what happens when a system receives the signals it was designed to run on.

The body, it turns out, has been waiting for the conversation to resume. The endocrine system never stopped listening — it was simply working with less than it needed to say anything clearly.